Alison I. Bernstein

2.1k total citations
27 papers, 914 citations indexed

About

Alison I. Bernstein is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Alison I. Bernstein has authored 27 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 9 papers in Neurology. Recurrent topics in Alison I. Bernstein's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Alison I. Bernstein is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Epigenetics and DNA Methylation (4 papers). Alison I. Bernstein collaborates with scholars based in United States, China and Germany. Alison I. Bernstein's co-authors include Gary W. Miller, Kristen A. Stout, Joseph Kochmanski, Karen L. O’Malley, Kelly M. Lohr, Amy R. Dunn, Minzheng Wang, Peng Jin, Shawn Alter and Sean Garrison and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Human Molecular Genetics.

In The Last Decade

Alison I. Bernstein

25 papers receiving 896 citations

Peers

Alison I. Bernstein
Danhui Zhang United States
Hsin‐Ping Liu Taiwan
Amy R. Dunn United States
J Botella Germany
Ruth A. Steingart Israel
Susanna Campesan United Kingdom
Chengyu Sheng China
Gregory A. O’Sullivan Germany
Alexandra Vaccaro Canada
Renee M. Miller United States
Danhui Zhang United States
Alison I. Bernstein
Citations per year, relative to Alison I. Bernstein Alison I. Bernstein (= 1×) peers Danhui Zhang

Countries citing papers authored by Alison I. Bernstein

Since Specialization
Citations

This map shows the geographic impact of Alison I. Bernstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison I. Bernstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison I. Bernstein more than expected).

Fields of papers citing papers by Alison I. Bernstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison I. Bernstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison I. Bernstein. The network helps show where Alison I. Bernstein may publish in the future.

Co-authorship network of co-authors of Alison I. Bernstein

This figure shows the co-authorship network connecting the top 25 collaborators of Alison I. Bernstein. A scholar is included among the top collaborators of Alison I. Bernstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison I. Bernstein. Alison I. Bernstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adams, Marie, et al.. (2025). Parkinson’s disease-associated alterations in DNA methylation and hydroxymethylation in human brain. npj Parkinson s Disease. 11(1). 363–363.
2.
3.
Patterson, Joseph R., Joseph Kochmanski, Christopher J. Kemp, et al.. (2024). Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. npj Parkinson s Disease. 10(1). 7–7. 6 indexed citations
4.
Bernstein, Alison I., et al.. (2024). Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease. Journal of Parkinson s Disease. 14(4). 643–656. 5 indexed citations
5.
Kuhn, Nathan C., Joseph R. Patterson, S. Zimmerman, et al.. (2023). Developmental exposure to the Parkinson’s disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice. Toxicological Sciences. 196(1). 99–111. 12 indexed citations
6.
Kochmanski, Joseph, Nathan C. Kuhn, & Alison I. Bernstein. (2022). Parkinson’s disease-associated, sex-specific changes in DNA methylation at PARK7 (DJ-1), SLC17A6 (VGLUT2), PTPRN2 (IA-2β), and NR4A2 (NURR1) in cortical neurons. npj Parkinson s Disease. 8(1). 120–120. 28 indexed citations
7.
Kochmanski, Joseph, Allyson Cole-Strauss, Christopher J. Kemp, et al.. (2020). Developmental exposure to the organochlorine pesticide dieldrin causes male-specific exacerbation of α-synuclein-preformed fibril-induced toxicity and motor deficits. Neurobiology of Disease. 141. 104947–104947. 25 indexed citations
8.
Kochmanski, Joseph & Alison I. Bernstein. (2020). The Impact of Environmental Factors on 5-Hydroxymethylcytosine in the Brain. Current Environmental Health Reports. 7(2). 109–120. 13 indexed citations
9.
10.
Dunn, Amy R., Kristen A. Stout, Kelly M. Lohr, et al.. (2017). Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proceedings of the National Academy of Sciences. 114(11). E2253–E2262. 93 indexed citations
11.
Patterson, Amanda L., et al.. (2017). Cervical HSV-2 infection causes cervical remodeling and increases risk for ascending infection and preterm birth. PLoS ONE. 12(11). e0188645–e0188645. 19 indexed citations
12.
Bernstein, Alison I., Yunting Lin, Li Lin, et al.. (2016). 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer’s disease modulate Tau-induced neurotoxicity. Human Molecular Genetics. 25(12). ddw109–ddw109. 51 indexed citations
13.
Lohr, Kelly M., Merry Chen, Carlie Hoffman, et al.. (2016). Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals. Toxicological Sciences. 153(1). 79–88. 36 indexed citations
14.
Cheng, Ying, Alison I. Bernstein, Dahua Chen, & Peng Jin. (2014). 5-Hydroxymethylcytosine: A new player in brain disorders?. Experimental Neurology. 268. 3–9. 66 indexed citations
15.
Inamdar, Arati A., Muhammad M. Hossain, Alison I. Bernstein, et al.. (2013). Fungal-derived semiochemical 1-octen-3-ol disrupts dopamine packaging and causes neurodegeneration. Proceedings of the National Academy of Sciences. 110(48). 19561–19566. 71 indexed citations
16.
Bernstein, Alison I. & Karen L. O’Malley. (2013). MPP+-induces PUMA- and p53-dependent, but ATF3-independent cell death. Toxicology Letters. 219(2). 93–98. 17 indexed citations
17.
Bernstein, Alison I., Kristen A. Stout, & Gary W. Miller. (2012). A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport. Journal of Neuroscience Methods. 209(2). 357–366. 19 indexed citations
18.
Bernstein, Alison I., Sean Garrison, Gerard P. Zambetti, & Karen L. O’Malley. (2011). 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Molecular Neurodegeneration. 6(1). 2–2. 72 indexed citations
19.
Kazkaz, K., Michael Foxe, Alison I. Bernstein, et al.. (2010). Operation of a 1-liter-volume gaseous argon proportional scintillation counter. Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment. 621(1-3). 267–277. 6 indexed citations
20.
Price, R. Arlen, et al.. (2001). A locus affecting obesity in human chromosome region 10p12. Diabetologia. 44(3). 363–366. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danhui Zhang Breakdown of academic impact, for papers by Hsin‐Ping Liu Breakdown of academic impact, for papers by Amy R. Dunn Breakdown of academic impact, for papers by J Botella Breakdown of academic impact, for papers by Ruth A. Steingart Breakdown of academic impact, for papers by Susanna Campesan Breakdown of academic impact, for papers by Chengyu Sheng Breakdown of academic impact, for papers by Gregory A. O’Sullivan Breakdown of academic impact, for papers by Alexandra Vaccaro Breakdown of academic impact, for papers by Renee M. Miller
Rankless by CCL
2026